Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

Last week African countries reported 2,532 new mpox cases, mostly in the Democratic Republic of the Congo (DRC) and Burundi, ...

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children 2-11 years ...

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN® mpox vaccine for countries in Africa impacted by the mpox outbreak.

raging through the Congo and other countries in Central Africa, younger people have become markedly vulnerable to infection. While Bavarian Nordic’s vaccine Jynneos is approved in several ...

An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said on Wednesday.

The risk outside of Africa appears low at this time ... Three vaccines recommended by the WHO are held in stockpiles worldwide: Bavarian Nordic's Jynneos (Imvanex or Imvamune outside the United ...

Revenue from the Travel Health business is now expected at approximate First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the ... the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...